Year Ended December 31, 2017 Comparative Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2018

Year Ended December 31, 2017 Comparative Data (Unaudited)

Schedule of Comparative Data

	For the year ended
	December 31, 2017
Revenues	$	—
Costs and Expenses:
Research and development		13,368,165
General and administrative		7,277,951
Loss From Operations		(20,646,116)
Other Income (Expense):
Change in fair value of derivative instruments—warrants and contingent consideration		5,618,598
Loss before income taxes		(15,027,518)
Income tax benefit		1,947,760
Net loss	$	(13,079,758)
Weighted Average Common Shares Outstanding
Basic and Diluted		9,678,329
Net loss per Common Share
Basic and Diluted	$	(1.35)